[Acute juvenile lymphatic leukemia in the Netherlands: study ALL II, 1973-5; Foundation Dutch Childhood Leukemia Study Group].
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000401:mortality; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009426:Netherlands; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate
Acute lymfatische leukemie bij kinderen in Nederland; onderzoek ALL II, 1973-1975; Stichting Nederlandse Werkgroep Leukemie bij Kinderen (SNWLK)